Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Researchers from University of Melbourne, Center for Animal Biotechnology detail findings in immunization
July 7th, 2009
A new study, 'M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens,' is now available. According to a study from Melbourne, Australia, "As the majority of human pathogens infect via a mucosal surface, delivery of killed vaccines by mucosal routes could potentially improve protection against many such organisms. Our ability to develop effective killed mucosal vaccines is inhibited by a lack of adjuvants that are safe and effective in humans." "The Ulex europaeus agglutinin I (UEA-I) lectin specifically binds M cells lining the murine gastrointestinal tract. We explored the potential for M-cell-targeted vaccination of...
Source: Cancer Weekly (2009-07-07)
|
